1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. BEAM THERAPEUTICS INC
Beam Therapeutics Inc
XNAS: BEAM
29.89 -1.96 (-6.15%)
1.3M
XNAS Volume

XNAS 14 May, 2026 1:32 PM (EDT)

Watchlist

Portfolio

Alert

Beam Therapeutics Inc - BEAM - stock price prediction, stock price target, analyst ratings from 17 analysts

Beam Therapeutics Inc has a share price target of US$ 51, revenue growth forecast of -48.8%, and profit growth estimate of -485.3% for FY26, based on top 17 analyst calls.